Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Crooks

Showing results (121-130 of 319) with videos related to

Pageof 32
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 23, 2011
Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseDavid B Horton, Kiran B Siripurapu, Guangrong Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2010
Phenyl ring-substituted lobelane analogs: inhibition of [³H]dopamine uptake at the vesicular monoamine transporter-2Justin R Nickell, Guangrong Zheng, Agripina G Deaciuc, et al.
Journal of Medicinal Chemistry|August 19, 2005
Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporterGuangrong Zheng, Linda P Dwoskin, Agripina G Deaciuc, et al.
Cancer Letters|December 28, 2020
Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLCGeri Traver, Konjeti R Sekhar, Peter A Crooks, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 2013
Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in ratsCarrie E Wilmouth, Guangrong Zheng, Peter A Crooks, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine releaseGuangrong Zheng, Sangeetha P Sumithran, Agripina G Deaciuc, et al.
The AAPS Journal|February 11, 2018
New Scaffold for Lead Compounds to Treat Methamphetamine Use DisordersNa-Ra Lee, Guangrong Zheng, Peter A Crooks, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2010
3-[Benzimidazo- and 3-[benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones as potent antimicrobial agentsB Suresh Kuarm, Y Thirupathi Reddy, J Venu Madhav, et al.
Acta Crystallographica. Section E, Structure Reports Online|April 28, 2011
cis-2,5-Bis(2-fluoro-5-meth-oxy-pheneth-yl)pyrrolidinium formatePurushothama Rao Ponugoti, Narsimha Reddy Penthala, Linda P Dwoskin, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
cis-1-Benzyl-pyrrolidine-2,5-dicarbonitrilePurushothama Rao Ponugoti, Narsimha Reddy Penthala, Linda P Dwoskin, et al.
Pageof 32

Showing results (121-130 of 319) with videos related to

Sort By:
Pageof 32
The Journal of Pharmacology and Experimental Therapeutics|July 23, 2011
Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseDavid B Horton, Kiran B Siripurapu, Guangrong Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2010
Phenyl ring-substituted lobelane analogs: inhibition of [³H]dopamine uptake at the vesicular monoamine transporter-2Justin R Nickell, Guangrong Zheng, Agripina G Deaciuc, et al.
Journal of Medicinal Chemistry|August 19, 2005
Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporterGuangrong Zheng, Linda P Dwoskin, Agripina G Deaciuc, et al.
Cancer Letters|December 28, 2020
Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLCGeri Traver, Konjeti R Sekhar, Peter A Crooks, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 2013
Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in ratsCarrie E Wilmouth, Guangrong Zheng, Peter A Crooks, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine releaseGuangrong Zheng, Sangeetha P Sumithran, Agripina G Deaciuc, et al.
The AAPS Journal|February 11, 2018
New Scaffold for Lead Compounds to Treat Methamphetamine Use DisordersNa-Ra Lee, Guangrong Zheng, Peter A Crooks, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2010
3-[Benzimidazo- and 3-[benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones as potent antimicrobial agentsB Suresh Kuarm, Y Thirupathi Reddy, J Venu Madhav, et al.
Acta Crystallographica. Section E, Structure Reports Online|April 28, 2011
cis-2,5-Bis(2-fluoro-5-meth-oxy-pheneth-yl)pyrrolidinium formatePurushothama Rao Ponugoti, Narsimha Reddy Penthala, Linda P Dwoskin, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
cis-1-Benzyl-pyrrolidine-2,5-dicarbonitrilePurushothama Rao Ponugoti, Narsimha Reddy Penthala, Linda P Dwoskin, et al.
Pageof 32